The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Mol. Biosci.
Sec. Metabolomics
Volume 11 - 2024 |
doi: 10.3389/fmolb.2024.1400622
This article is part of the Research Topic Current Trends in Targeted and Non-Targeted Metabolomics in Analytical Toxicology View all 8 articles
Comparative Analysis of Anticoagulant Influence on PMI Estimation in Porcine Blood Using GC-MS Metabolomics
Provisionally accepted- 1 Medical University of Bialystok, Bialystok, Podlaskie Voivodeship, Poland
- 2 Central Police Forensic Laboratory (CLKP), Warsaw, Masovian, Poland
- 3 Autonomous University of Barcelona, Barcelona, Catalonia, Spain
- 4 University of Wrocław, Wrocław, Silesian, Poland
- 5 Forensic Laboratory of the Voivodeship Police Headquarters in Bialystok, Białystok, Poland
Accurate post-mortem interval (PMI) estimation is essential in forensic investigations.Although various methods for PMI determination have been developed, only an approximate estimation is still achievable, and an accurate PMI indication is still challenging. Therefore, in this study, we employed gas chromatography-mass spectrometry (GC-MS)-based metabolomics to assess post-mortem changes in porcine blood samples collected with and without the addition of anticoagulant (EDTA). Our study aimed to identify metabolites dependent on the EDTA addition and time (taking into account the biodiversity of the studied organism) and those that are time-dependent but resistant to the addition of an anticoagulant.The experiment was performed on blood samples collected from 16 animals (domestic pig, breed: Polish Large White), 8 with and 8 without EDTA addition. The moment of death (time 0) and 15 additional time points (from 3 to 168 hours after death) were selected to examine changes in metabolites' levels in specific time intervals. We employed linear mixed models to study the relationship between metabolite intensities, time and presence of EDTA while accounting for the effect of individual pigs.We confirmed that the intensity of 16 metabolites (mainly amino acids) significantly depends on PMI and the presence of EDTA. However, the intensity of the ideal biomarker(s) for PMI estimation should be determined only by the time after death and not by external factors such as the presence of the anticoagulant agent. Thus, we identified 41 metabolites with time-dependent intensities that were not susceptible to EDTA presence. Finally, we assessed the performance of these metabolites in a PMI predictive model. Citraconic acid yielded one of the lowest errors in general PMI estimation (32.82 h). Moreover, similar errors were observed for samples with and without EDTA (33.32 h and 32.34 h, respectively). Although the small sample size and information leak in predictive modelling prevent drawing definite conclusions, citraconic acid shows potential as a robust PMI estimator.
Keywords: Post-mortem time interval (PMI) estimation, animal model, Blood bimarkers, Metabolomics, GC-MS
Received: 13 Mar 2024; Accepted: 18 Dec 2024.
Copyright: © 2024 Mojsak, Samczuk, Klimaszewska, Burdukiewicz, Chilimoniuk, Grzesiak, Pietrowska, Ciborowska, Niemcunowicz-Janica, Kretowski, Ciborowski and Szeremeta. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Paulina Samczuk, Medical University of Bialystok, Bialystok, 15-089, Podlaskie Voivodeship, Poland
Jaroslaw Chilimoniuk, Medical University of Bialystok, Bialystok, 15-089, Podlaskie Voivodeship, Poland
Justyna Ciborowska, Forensic Laboratory of the Voivodeship Police Headquarters in Bialystok, Białystok, Poland
Anna Niemcunowicz-Janica, Medical University of Bialystok, Bialystok, 15-089, Podlaskie Voivodeship, Poland
Adam Kretowski, Medical University of Bialystok, Bialystok, 15-089, Podlaskie Voivodeship, Poland
Michal Ciborowski, Medical University of Bialystok, Bialystok, 15-089, Podlaskie Voivodeship, Poland
Michal Szeremeta, Medical University of Bialystok, Bialystok, 15-089, Podlaskie Voivodeship, Poland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.